RE: Defining the limits of radical cytoreductive surgery in ovarian cancer

被引：1
|
作者：
Cliby, William [1 ]
Aletti, Giovanni [2 ]
Chi, Dennis [3 ]
Bristow, Robert [4 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
[2] European Inst Oncol, Milan, Italy
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Univ Calif, Irvine Med Ctr, Orange, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷 / 02期
关键词：
RISK;
D O I：
10.1016/j.ygyno.2012.01.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：509 / 510
页数：2
相关论文
共 50 条
  • [41] Hepatic hilum cytoreductive surgery for ovarian cancer relapse
    Gracia, Myriam
    Fondevila, Constantino
    Hernandez, Alicia
    Prieto, Isabel
    Alonso-Espias, Maria
    Zapardiel, Ignacio
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [42] Rectosigmoid resection morbidity in ovarian cancer cytoreductive surgery
    Usmani, Afshan Saeed
    Yasin, Iqra
    Bin Asif, Rehan
    Khalid, Nazish
    Syed, Aamir Ali
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (06) : 1284 - 1287
  • [43] Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer
    Luna-Abanto, Jorge
    Garcia Ruiz, Luis
    Laura Martinez, Jheff
    Alvarez Larraondo, Manuel
    Villoslada Terrones, Vladimir
    JOURNAL OF GYNECOLOGIC SURGERY, 2020, 36 (02) : 70 - 75
  • [44] Cytoreductive surgery in primary advanced epithelial ovarian cancer
    Luca Ansaloni
    Federico Coccolini
    Fausto Catena
    Luigi Frigerio
    Robert E Bristow
    World Journal of Obstetrics and Gynecology, 2013, (04) : 116 - 123
  • [45] Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
    Harter, P.
    Sehouli, J.
    Vergote, I
    Ferron, G.
    Reuss, A.
    Meier, W.
    Greggi, S.
    Mosgard, B. J.
    Selle, F.
    Guyon, F.
    Pomel, C.
    Lecuru, F.
    Zang, R.
    Avail-Lundqvist, E.
    Kim, J-W
    Ponce, J.
    Raspagliesi, F.
    Kristensen, G.
    Classe, J-M
    Hillemanns, P.
    Jensen, P.
    Hasenburg, A.
    Ghaem-Maghami, S.
    Mirza, M. R.
    Lund, B.
    Reinthaller, A.
    Santaballa, A.
    Olaitan, A.
    Hilpert, F.
    du Bois, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (23): : 2123 - 2131
  • [46] Cytoreductive Surgery for Advanced Ovarian Cancer: Quo Vadis?
    Schorge, John O.
    Garrett, Leslie A.
    Goodman, Annekathryn
    ONCOLOGY-NEW YORK, 2011, 25 (10): : 928 - 934
  • [47] Ovarian cancer in the overweight and obese: Disparities in cytoreductive surgery
    Fleury, A.
    Kushnir, C.
    Giuntoli, R.
    Diaz-Montes, T.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : S23 - S23
  • [48] The role of secondary cytoreductive surgery for recurrent ovarian cancer
    Güngör, M
    Ortaç, F
    Arvas, M
    Kösebay, D
    Sönmezer, M
    Köse, K
    GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 74 - 79
  • [49] Secondary cytoreductive surgery for recurrent epithelial ovarian cancer
    Tay, EH
    Grant, PT
    Gebski, V
    Hacker, NF
    OBSTETRICS AND GYNECOLOGY, 2002, 99 (06): : 1008 - 1013
  • [50] Neoadjuvant chemotherapy and cytoreductive surgery in epithelial ovarian cancer
    Siriwan Tangjitgamol
    Jitti Hanprasertpong
    Marta Cubelli
    Claudio Zamagni
    World Journal of Obstetrics and Gynecology, 2013, (04) : 153 - 166
12345